mPGES-1 inhibitors (NovaSAID/Cadila)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamemPGES-1 inhibitors (NovaSAID/Cadila)
Drug Alias NamemPGES-1 inhibitors (NovaSAID)prostaglandin E synthase inhibitors (NovaSAID)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin E synthase inhibitors
TargetsProstaglandin E synthase
Therapy Area/IndicationsPainFeverInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovaSAID AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovaSAID ABCadila Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsPainFeverInflammation

Other Information

ATC CodeN/A
Related LinksN/A